Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVEAL anacetrapib lipid-modification trial
ISRCTN48678192Phase 3Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Aug 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in atherosclerotic disease comparing Anacetrapib plus atorvastatin with Placebo plus atorvastatin (2 arms). Primary endpoint: Major coronary events during scheduled treatment period. Started Aug 2011; status: active, not recruiting.
02
Drugs
anacetrapib
03
Conditions
atherosclerotic disease
Beyond the preview
Go deeper on ISRCTN48678192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48678192.